Pharmicell

The World’s First & The World’s Best Pioneering Stem Cell Therapeutics For the past ten years, Pharmicell Co., Ltd has devoted itself to the development of stem cell therapeutics for incurable diseases. Pharmicell’s unceasing efforts and dedication in stem cell therapeutic research gained NDA approval from the KFDA in 2011. Since then, the world’s first stem cell therapeutics has been successfully launched. It is well known that stem cell therapeutics has been used to treat rare and incurable diseases. Pharmicell has focused on stem cell therapeutics to treat various diseases using bone marrow-derived mesenchymal stem cells and peripheral blood-derived hematopoietic stem cells. We strive to bring hope to patients suffering from incurable diseases by developing more advanced stem cell therapeutics with our innovative research and technology. In addition, we provide a stem cell banking service for adult stem cells and cord-blood. This service is based on our rich experience and know-how accumulated from the developing process of stem cell therapeutics. We are also engaged in CMO services for researchers to accelerate the development of stem cell therapeutics. For our technology consulting and CMO services to meet global standards, we possess cutting edge sterilization facilities and a cell manufacturing and quality management system. Also, we are involved in manufacturing and selling cosmetics containing stem cell culturing media, obtained through stem cell culture technology.